BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31719941)

  • 1. Atrial fibrillation observed in a patient with esophageal cancer treated with fluorouracil.
    Moriyama S; Yokoyama T; Irie K; Ito M; Tsuchihashi K; Fukata M; Kusaba H; Maruyama T; Akashi K
    J Cardiol Cases; 2019 Nov; 20(5):183-186. PubMed ID: 31719941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxysmal atrial fibrillation during intracoronary acetylcholine provocation test.
    Saito Y; Kitahara H; Shoji T; Tokimasa S; Nakayama T; Sugimoto K; Fujimoto Y; Kobayashi Y
    Heart Vessels; 2017 Jul; 32(7):902-908. PubMed ID: 28005169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between paroxysmal atrial fibrillation and coronary artery spasm.
    Kawakami T; Ohno H; Tanaka N; Ishihara H; Kobayakawa H; Sakurai T
    Pacing Clin Electrophysiol; 2014 May; 37(5):591-6. PubMed ID: 24215419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of 5-Fluorouracil-Induced Cardiac Arrest.
    Ray JC; Cho P; Dragon M; Graham CG
    J Emerg Med; 2016 Jan; 50(1):e1-6. PubMed ID: 26482827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prinzmetal angina (Coronary vasospasm) associated with 5-fluorouracil chemotherapy.
    Ben-Yakov M; Mattu A; Brady WJ; Dubbs SB
    Am J Emerg Med; 2017 Jul; 35(7):1038.e3-1038.e5. PubMed ID: 28283339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for remote ischemic conditioning in preventing 5-fluorouracil-induced coronary vasospasm?
    Chong J; Ho AF; Yap J; Bulluck H; Hausenloy DJ
    Cond Med; 2019 Oct; 2(5):204-212. PubMed ID: 32133437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Fluorouracil-related Cardiotoxicity with Coronary Vasospasms.
    Faheem B; Kania B; Ashkar H; Bondili L; Maroules M
    J Community Hosp Intern Med Perspect; 2022; 12(5):71-74. PubMed ID: 36262502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotoxicity of 5-flourouracil: two case reports.
    Tutkun A; Inanli S; Caymaz O; Ayanoğlu E; Duman D
    Auris Nasus Larynx; 2001 Apr; 28(2):193-6. PubMed ID: 11240331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Vasospasm and Microcirculatory Dysfunction in Fluoropyrimidine-Induced Ischemic Heart Disease.
    Fabin N; Bergami M; Cenko E; Bugiardini R; Manfrini O
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacological response of ischemia-related atrial fibrillation in dogs: evidence for substrate-specific efficacy.
    Rivard L; Sinno H; Shiroshita-Takeshita A; Schram G; Leung TK; Nattel S
    Cardiovasc Res; 2007 Apr; 74(1):104-13. PubMed ID: 17316585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-fluorouracil-induced coronary vasospasm.
    Shoemaker LK; Arora U; Rocha Lima CM
    Cancer Control; 2004; 11(1):46-9. PubMed ID: 14749623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy.
    Karakulak UN; Aladağ E; Maharjan N; Övünç K
    Turk Kardiyol Dern Ars; 2016 Jan; 44(1):71-4. PubMed ID: 26875134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological versus invasive treatment in patients with atrial fibrillation].
    Pytkowski M; Jankowska A; Kraska A; Sterliński M; Kowalik I; Krzyzanowski W; Szwed H
    Pol Arch Med Wewn; 2004 Jun; 111(6):703-7. PubMed ID: 15508793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular fibrillation as a likely consequence of capecitabine-induced coronary vasospasm.
    Shah NR; Shah A; Rather A
    J Oncol Pharm Pract; 2012 Mar; 18(1):132-5. PubMed ID: 21321041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary Artery Vasospasm Induced by 5-fluorouracil: Proposed Mechanisms, Existing Management Options and Future Directions.
    Chong JH; Ghosh AK
    Interv Cardiol; 2019 May; 14(2):89-94. PubMed ID: 31178935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary vasospasm caused by intravenous infusion of dexmedetomidine: Unrecognized pitfall of catheter ablation procedures of atrial fibrillation.
    Furui K; Morishima I; Kanzaki Y; Tsuboi H
    J Cardiol Cases; 2019 Dec; 20(6):221-224. PubMed ID: 31762838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle.
    Mosseri M; Fingert HJ; Varticovski L; Chokshi S; Isner JM
    Cancer Res; 1993 Jul; 53(13):3028-33. PubMed ID: 8391384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation after coronary artery bypass surgery: P wave signal averaged ECG, clinical and angiographic variables in risk assessment.
    Aytemir K; Aksoyek S; Ozer N; Aslamaci S; Oto A
    Int J Cardiol; 1999 Apr; 69(1):49-56. PubMed ID: 10362372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stenosis of the right coronary artery and retrograde cardioplegia predispose patients to atrial fibrillation after coronary artery bypass grafting.
    Pehkonen E; Honkonen E; Mäkynen P; Kataja M; Tarkka M
    Thorac Cardiovasc Surg; 1998 Jun; 46(3):115-20. PubMed ID: 9714484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Angina pectoris and ST-elevation after chemotherapy with 5-fluorouracil].
    Spencker S; Schmittel A; Westermann D; Marek A; Schultheiss HP; Witzenbichler B
    Internist (Berl); 2007 Jan; 48(1):69-72, 74. PubMed ID: 17177034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.